PSA can precisely classify only 74.7% of BPH cases compared to HC, 62.7% of BPH + PC cases compared to HC, 71.8% of PC cases compared to HC, and 56.5% of PC cases compared to BPH. Here, KLK3 is linked to benign prostatic hyperplasia.